DE60216807D1 - Triazepin-derivate als neurotrope mittel - Google Patents

Triazepin-derivate als neurotrope mittel

Info

Publication number
DE60216807D1
DE60216807D1 DE60216807T DE60216807T DE60216807D1 DE 60216807 D1 DE60216807 D1 DE 60216807D1 DE 60216807 T DE60216807 T DE 60216807T DE 60216807 T DE60216807 T DE 60216807T DE 60216807 D1 DE60216807 D1 DE 60216807D1
Authority
DE
Germany
Prior art keywords
neurotrope
agents
disease
triazepine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60216807T
Other languages
English (en)
Other versions
DE60216807T2 (de
Inventor
Zhihua Sui
P Walsh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of DE60216807D1 publication Critical patent/DE60216807D1/de
Publication of DE60216807T2 publication Critical patent/DE60216807T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE60216807T 2001-10-04 2002-10-04 Triazepin-derivate als neurotrope mittel Expired - Lifetime DE60216807T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32692701P 2001-10-04 2001-10-04
US326927P 2001-10-04
PCT/US2002/031679 WO2003028734A1 (en) 2001-10-04 2002-10-04 Triazepine derivatives as neurotrophic agents

Publications (2)

Publication Number Publication Date
DE60216807D1 true DE60216807D1 (de) 2007-01-25
DE60216807T2 DE60216807T2 (de) 2007-10-04

Family

ID=23274355

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60216807T Expired - Lifetime DE60216807T2 (de) 2001-10-04 2002-10-04 Triazepin-derivate als neurotrope mittel

Country Status (9)

Country Link
EP (1) EP1446127B1 (de)
JP (1) JP2005504823A (de)
AT (1) ATE347893T1 (de)
AU (1) AU2002334837B2 (de)
CA (1) CA2462643A1 (de)
DE (1) DE60216807T2 (de)
ES (1) ES2278078T3 (de)
MX (1) MXPA04003215A (de)
WO (1) WO2003028734A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1240691C (zh) * 2001-12-06 2006-02-08 中国人民解放军军事医学科学院毒物药物研究所 取代五元氮杂环类化合物及其预防和治疗神经退行性疾病的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
FR1511147A (fr) * 1966-12-16 1968-01-26 Soc Ind Fab Antibiotiques Sifa Nouveaux dérivés de la 11 h-dibenzotriazépine-1, 2, 5 et leurs sels, et procédéde préparation

Also Published As

Publication number Publication date
EP1446127B1 (de) 2006-12-13
ES2278078T3 (es) 2007-08-01
MXPA04003215A (es) 2005-01-25
AU2002334837B2 (en) 2007-03-15
JP2005504823A (ja) 2005-02-17
DE60216807T2 (de) 2007-10-04
CA2462643A1 (en) 2003-04-10
ATE347893T1 (de) 2007-01-15
WO2003028734A1 (en) 2003-04-10
EP1446127A1 (de) 2004-08-18

Similar Documents

Publication Publication Date Title
MXPA05002420A (es) Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos.
CA2501799A1 (en) Pyrazole compounds for treatment of neurodegenerative disorders
GB0129260D0 (en) Pharmaceutical compositions and their uses
NO20053644L (no) (2S)-2-[(4S)-4-(2,2-difluorvinyl)-2-oksopyrrolidinyl ]butanamid og farmasoytisk preparat
BR0214035A (pt) Composto
MY138252A (en) Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease
ATE385419T1 (de) Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat
ATE440087T1 (de) 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
GB0225475D0 (en) Therapeutic agents
EP1689713A4 (de) Benzylether und benzylaminoverbindungen als inhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
BR0210028A (pt) Agentes antibacterianos
CA2534532A1 (en) Compounds for the treatment of neurodegenerative disorders
DE60308699D1 (en) 2-phenylamino-4-trifluoromethyl-5-(benzyl- oder pyridin-4-ylmethyl)carbamoylpyrimidin-derivate als selektive cb2 cannabinoid-rezeptor modulatoren
DE60024857D1 (de) Neue verbindungen
NO20010940D0 (no) TAN-1057 derivater
ATE371724T1 (de) Behandlung neurodegenerativer krankheiten
ATE294794T1 (de) N-heterocyclylhydrazide als neurotrophe mittel
DE602004019500D1 (en) 4-substituirte-5-cyano-1h-pyrimidin-6-(th)iones als als gsk-3-hemmer
DE50011645D1 (de) Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung
DE60216807D1 (de) Triazepin-derivate als neurotrope mittel
ATE421961T1 (de) Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält
BR0113814A (pt) Amidas de ácido fenilciclohexanocarboxìlico e sua aplicação
DE602004014115D1 (de) Neue amidderivate von 2,2,3,3-tetramethylcyclopropancarbonsäure
DE60006032D1 (de) 3-(3-Hydroxyphenyl)-3-amino-propionamidderivate
BR9900024A (pt) Biciclo[3.1.0]hexanos e compostos relacionados.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition